Moss Adams Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Moss Adams Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$301K	Buy	571 +38	+7%	+$21.3K	0.02%	222
2026 Q1	$299K	Sell	533 -8	-1%	-$5.13K	0.02%	205
2025 Q4	$366K	Buy	541 +13	+2%	+$8.85K	0.03%	172
2025 Q3	$337K	Buy	528 +17	+3%	+$10.3K	0.03%	174
2025 Q2	$274K	Sell	511 -69	-12%	-$33K	0.02%	205
2025 Q1	$244K	Buy	580 +52	+10%	+$22.6K	0.03%	178
2024 Q4	$218K	Buy	528 +22	+4%	+$9.65K	0.02%	190
2024 Q3	$256K	Buy	+506	New	+$246K	0.03%	166
2024 Q2	–	Sell	-473	Closed	-$255K	–	181
2024 Q1	$255K	Buy	+473	New	+$258K	0.04%	124

Other funds holding IDXX

MBI

Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Boston, Massachusetts $10.3B AUM 3.26% 1-Year Est. Return

Moss Adams Wealth Advisors's IDXX Position: Q2 2026 in Review

Moss Adams Wealth Advisors increased its Idexx Laboratories (IDXX) stake by 7.1% in Q2 2026, buying an estimated $21.3K and bringing the position to 571 shares worth $301K. The position accounts for 0.02% of the portfolio, ranked #222.

Moss Adams Wealth Advisors first reported a position in IDXX in Q1 2024 and has held it in 9 quarters since. The position peaked at $366K in Q4 2025. 485 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Moss Adams Wealth Advisors held 571 shares of Idexx Laboratories worth $301K as of Q2 2026.
Moss Adams Wealth Advisors bought 38 Idexx Laboratories shares in Q2 2026, an estimated $21.3K.
Idexx Laboratories made up 0.02% of Moss Adams Wealth Advisors's portfolio in Q2 2026, its #222 holding.
Moss Adams Wealth Advisors first reported a position in Idexx Laboratories in Q1 2024 and has held it in 9 quarters since.
Moss Adams Wealth Advisors's Idexx Laboratories position peaked at $366K in Q4 2025.
485 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.